Goldman Sachs names Healius (ASX:HLS) as a value share to buy

The Healius Ltd (ASX:HLS) share price could still go a lot higher from here according to one leading broker…
The post Goldman Sachs names Healius (ASX:HLS) as a value share to buy appeared first on The Motley Fool Australia. –

asx brokers

The Healius Ltd (ASX: HLS) share price was a particularly positive performer on Wednesday.

The healthcare company’s shares jumped 7.5% to $3.90 following the release of a positive trading update.

What was in the Healius update?

As you might have guessed from the Healius share price reaction, the company has been performing very positively so far in FY 2021.

Healius advised that its Pathology business continued its strong revenue growth in October and November thanks to a combination of COVID-19 testing and non-COVID revenue growth.

The Imaging and Day Hospitals businesses were also performing positively, with growth being delivered across all states.

This strong form and the recent completion of its medical centres sale to BGH Capital, led to the company announcing a $200 million share buyback. This represents almost 10% of its shares outstanding.

Can the Healius share price go higher?

Although the Healius share price hit a two-year high on Wednesday, one leading broker believes it can still go higher.

According to a note out of Goldman Sachs, its analysts believe Healius’ shares are great value and expect consensus earnings upgrades to drive its shares higher in the future.

The broker has a buy rating and $4.40 price target on its shares. This implies potential upside of almost 13% over the next 12 months excluding dividends.

It commented: “Prior to today, we were forecasting earnings +20-25% above consensus and, whilst we make only modest revisions to operating profits today, we post +7-22% EPS upgrades to reflect the new share buy-back program.”

“Trading at 10.2x pre-AASB EBITDA (or 6.0x post-AASB) for +8% EBITDA CAGR (FY21-24E), HLS is one of the few value-oriented stocks in the ASX healthcare sector, and we believe it should be considered a core holding ahead of CY21. We expect consensus upgrades and multiple re-rating to drive further stock performance through the mid-term,” it concluded.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Goldman Sachs names Healius (ASX:HLS) as a value share to buy appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!